logo-loader
NASDAQ:IOVA

Iovance Biotherapeutics

Receive alerts
Market:
NASDAQ
Market Cap:
$3.12 billion
Price
24.76 USD
Change
-0.48%
52 weeks high
29.64
52 weeks low
9.22

In brief

IOVANCE Biotherapeutics is focused on the development and commercialization of autologous cellular immunotherapies optimizing personalized, tumor-directed Tumor Infiltrating Lymphocytes (TIL).